USA - NASDAQ:CMAX - US14171W2026 - Common Stock
The current stock price of CMAX is 0.4215 USD. In the past month the price decreased by -79.13%. In the past year, price decreased by -98.02%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.25 | 97.71B | ||
| CI | THE CIGNA GROUP | 9.29 | 69.66B | ||
| LH | LABCORP HOLDINGS INC | 16.09 | 21.15B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 203.73 | 19.85B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.13 | 19.79B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.23 | 15.68B | ||
| HIMS | HIMS & HERS HEALTH INC | 56.64 | 10.24B | ||
| DVA | DAVITA INC | 12.52 | 8.68B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.37B | ||
| CHE | CHEMED CORP | 21.09 | 6.76B | ||
| RDNT | RADNET INC | 213.64 | 5.92B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 60.09 | 5.85B |
CareMax, Inc. provides medical services through physicians and health care professionals. The company is headquartered in Miami, Florida and currently employs 1,450 full-time employees. The company went IPO on 2020-07-21. The company operates over 56 centers and managed affiliated providers across 10 states that offer a suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Its CareOptimize is an end-to-end technology platform that aggregates and analyzes data using proprietary algorithms and machine learning to support more informed care delivery decisions and to focus care decisions on preventative chronic disease management and the social determinants of health. The firm offers 24/7 access to care through employed providers and provides a comprehensive suite of high-touch health care and social services for its patients.
CAREMAX INC
1000 Nw 57Th Court, Suite 400
Miami FLORIDA US
CEO: Steven Hochberg
Employees: 1450
Phone: 13056863912
CareMax, Inc. provides medical services through physicians and health care professionals. The company is headquartered in Miami, Florida and currently employs 1,450 full-time employees. The company went IPO on 2020-07-21. The company operates over 56 centers and managed affiliated providers across 10 states that offer a suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Its CareOptimize is an end-to-end technology platform that aggregates and analyzes data using proprietary algorithms and machine learning to support more informed care delivery decisions and to focus care decisions on preventative chronic disease management and the social determinants of health. The firm offers 24/7 access to care through employed providers and provides a comprehensive suite of high-touch health care and social services for its patients.
The current stock price of CMAX is 0.4215 USD. The price decreased by -26.22% in the last trading session.
CMAX does not pay a dividend.
CMAX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
7 analysts have analysed CMAX and the average price target is 43.25 USD. This implies a price increase of 10160.5% is expected in the next year compared to the current price of 0.4215.
The Revenue of CAREMAX INC (CMAX) is expected to grow by 5.97% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
CAREMAX INC (CMAX) has a market capitalization of 1.61M USD. This makes CMAX a Nano Cap stock.
ChartMill assigns a fundamental rating of 1 / 10 to CMAX. CMAX may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months CMAX reported a non-GAAP Earnings per Share(EPS) of -173.48. The EPS decreased by -1080.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -172.42% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
7 analysts have analysed CMAX and the average price target is 43.25 USD. This implies a price increase of 10160.5% is expected in the next year compared to the current price of 0.4215.
For the next year, analysts expect an EPS growth of 83.76% and a revenue growth 5.97% for CMAX